SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 25, 2000
(October 25, 2000)
ENDO PHARMACEUTICALS HOLDINGS INC.
-------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 39040 13-4022871
-------------------------------------------------------------------------------
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of Identification No.)
incorporation)
223 Wilmington-West Chester Pike
Chadds Ford, Pennsylvania 19317
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(610) 558-9800
-------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
-------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
------------
On October 25, 2000, the Registrant issued a press release, a
copy of which is filed herewith as Exhibit 99.1 and is incorporated herein
by reference.
Item 7. Financial Statements and Exhibits.
---------------------------------
(a) Financial Statements of Business Acquired.
Not applicable
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Exhibit Number Description
-------------- -----------
99.1 Press release issued by Endo Pharmaceuticals Holdings Inc.
on October 25, 2000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
ENDO PHARMACEUTICALS HOLDINGS INC.
(Registrant)
By: /S/ CAROL A. AMMON
-----------------------------------------
Name: Carol A. Ammon
Title: President & Chief Executive Officer
Dated: October 25, 2000
INDEX TO EXHIBITS
Exhibit No. Description
----------- -----------
99.1 Press release issued by Endo Pharmaceuticals Holdings Inc.
on October 25, 2000
